1.
J Am Acad Dermatol
; 62(4): 711-2, 2010 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20227589
2.
Cutis
; 81(5): 431-4, 2008 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-18543595
RESUMEN
Alopecia universalis often responds poorly to standard therapies. We report how a novel treatment option, alefacept, was successfully used in the management of a 21-year-old woman with alopecia universalis. The patient responded with complete regrowth of scalp and body hair after a single 12-week treatment course of alefacept. In addition, a review of the literature was performed pertaining to the use of biologic agents in the treatment of alopecia areata/universalis to determine which agents have a potential role in the treatment of this often refractory disease.